Sweeteners · Metabolic & Cardiometabolic
non-nutritive and artificial sweeteners induces cephalic-phase insulin response via sweet-taste receptors despite zero calories
In plain terms: Do zero-calorie sweeteners still spike insulin just from tasting sweet?
Refuted Sweeteners 🔬 Includes disconfirming
RefutedContestedStrong support
consensus score -0.63
No — controlled trials and meta-analyses show non-nutritive sweeteners cause little to no acute rise in glucose or insulin, so a meaningful cephalic-phase insulin surge from sweet taste alone is not supported.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
1 support 10 contradict 2 tested null 4 mixed · 17 sources, 11 independent groups · 1 superseded — pooled inside a review, counted once
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sae Iab T et al 2020 · study_type: RCT | RCT | mixed | low | Small crossover pilot (n=10) comparing water, sucrose, sucralose, and maltodextrin preloads; plasma glucose (not insulin) was measured, and glucose spiked only in the absence of sweet taste (maltodextrin, calories without sweetness), while |
| Lasschuijt MP et al 2020 · study_type: meta-analysis | meta-analysis | contradicts | high | Systematic review (PRISMA) of 50 human studies on cephalic phase insulin responses (CPIR) to food cues (including sweet taste/NNS); an insulin rise (>=1 uIU/mL) occurred in only 41% of treatments and was statistically significant from basel |
| Brown 2012 · Diabetes Care | RCT | tested-null | low | Diet soda (sucralose/ace-K) increased GLP-1 secretion in youths — evidence of some sweet-taste gut-hormone signaling, but this is incretin not a cephalic insulin spike, and did not raise insulin problematically. |
| McGlynn 2022 · JAMA Netw Open | meta-analysis | tested-null | high | Substituting NNS beverages for sugary drinks improved weight and cardiometabolic risk vs no metabolic-syndrome harm — opposite of the predicted insulin-driven harm. |
| Zhang 2023 · Nutrients | meta-analysis | contradicts | high | Network meta-analysis: non-nutritive sweetened beverages had no adverse postprandial glucose/insulin/incretin effect relative to water. |
| Ford 2011 · Eur J Clin Nutr | RCT | contradicts | moderate | Oral ingestion of sucralose did not raise plasma insulin, GLP-1 or PYY in healthy subjects. ↩ SUPERSEDED — pooled in the review above, counted once |
| Lertrit 2018 · Nutrition | RCT | contradicts | moderate | Sucralose exposure did not alter insulin secretion, insulin sensitivity or GLP-1 in healthy subjects. |
| Abdallah 1997 · Am J Clin Nutr | RCT | contradicts | moderate | Sucking an aspartame sweet tablet produced no cephalic-phase insulin release in normal-weight men. |
| Otsuki T et al 2026 · study_type: animal | animal | contradicts | moderate | In mice, 2 days of NNS consumption impaired reinforced cephalic phase insulin release (CPIR) that had been conditioned by glucose-solution pairing, and worsened glucose tolerance. NNS did not trigger/enhance CPIR themselves; instead they bl |
| Gomez-Arauz 2019 · J Diabetes Res | RCT | supports | low | A single 48 mg sucralose sip stimulated insulin secretion during an OGTT in healthy young adults, providing limited support for a taste-triggered response. |
| Glendinning 2015 · Am J Physiol | animal | contradicts | high | In mice, sugar-induced cephalic insulin release occurred via a sweet-receptor-independent pathway and artificial sweeteners did not trigger it, arguing against taste-alone insulin spikes. |
| Pullicin 2023 · Appetite | RCT | mixed | moderate | Glucose and maltodextrin elicited cephalic insulin release requiring both glucose sensing and sweet taste, so sweetness alone is insufficient to guarantee the response. |
| Greyling 2020 · Am J Clin Nutr | meta-analysis | contradicts | high | Meta-analysis of RCTs: low-energy sweeteners produced no acute rise in blood glucose or insulin vs control. |
| Pullicin 2026 · Physiol Behav | RCT | mixed | moderate | Sucralose produced only a trending/non-significant mean insulin and c-peptide rise, far weaker than glucose, indicating sweet taste alone rarely reliably spikes insulin. |
| Lutnik M et al 2024 · study_type: RCT | RCT | contradicts | moderate | Randomized crossover trial in 17 healthy humans comparing 30g glucose vs 30g ENSO 16 (a 16-sweetener blend); insulin and C-peptide AUC(0-180min) were significantly greater after glucose than after the sweetener blend, with only a small rise |
| Gibbons C et al 2024 · study_type: RCT | RCT | contradicts | high | Randomized crossover trial (n=53 overweight/obese adults, SWEET consortium) comparing biscuits sweetened with sucrose vs neotame vs Stevia Rebaudioside M; postprandial insulin (2-h iAUC) was significantly LOWER after neotame and StRebM than |
| Boxall 2025 · Adv Nutr | meta-analysis | contradicts | moderate | Aspartame showed little to no effect on glucose/insulin acutely or long term across 100 experiments (certainty very low but consistently null). |
| Dhillon J et al 2017 · study_type: RCT | RCT | mixed | moderate | Sham-feeding RCT in 64 overweight/obese adults comparing sucrose vs sucralose in solid/beverage form; a subset of participants ('responders') showed a significant rise in serum insulin 2 minutes after oral exposure to sucralose, especially |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.